EUVIMEDEUVIMED entdecken
Korrektur

Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors

Stem Cells · 22.07.2026 · 44 (8)

DOI: 10.1093/stmcls/sxag034 ↗

Kurz gefasst

Korrektur in der Zeitschrift Stem Cells, online erschienen am 30.07.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors. Stem Cells, 44(8). https://doi.org/10.1093/stmcls/sxag034

Vancouver

Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors. Stem Cells. 2026;44(8). doi:10.1093/stmcls/sxag034

BibTeX
@article{euvimed2026,
  title = {Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors},
  journal = {Stem Cells},
  year = {2026},
  volume = {44},
  number = {8},
  doi = {10.1093/stmcls/sxag034}
}
Kostenlos starten →